Pharma Pressreleases

This section covers the managerial aspects in the Pharma industry.

LAM Announces New Data Demonstrating High Diagnostic Potential Of Cell-Free DNA Methylation Assay For Early, Non-Invasive Detection Of Liver, Breast And Colorectal Cancers At AACR 2019

Sunday, March 31, 2019
PR Newswire

IRVINE Calif March PRNewswire Laboratory for Advanced Medicine LAM a commercialstage medical technology company focused on developing innovative technologies for the early diagnosis of cancers today announced new data at the American Association f...

For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size

Sunday, March 31, 2019
PR Newswire

ATLANTA March PRNewswire Combining immunotherapy with chemotherapy shows promise for treating advanced pancreatic cancer shrinking tumors in a majority of evaluable patients out of as of an interim analysis of phase b data from an ongoing tria...

Apexigen Announces New Clinical Data On APX005M In Combination Therapy For Pancreatic Cancer At The AACR Annual Meeting 2019

Sunday, March 31, 2019
PR Newswire

SAN CARLOS Calif March PRNewswire Apexigen Inc a clinicalstage biopharmaceutical company today announced the presentation of new clinical data on APXM in combination therapy in patients with metastatic pancreatic cancerThe data are being presented...

Cyteir Therapeutics Announces New Data Demonstrating Lead Compound CYT-0851 is Active Against Lymphomas and Solid Tumors, Synergistic with PARP Inhibitors

Sunday, March 31, 2019
PR Newswire

LEXINGTON Mass March PRNewswire Cyteir Therapeutics a leader in the discovery and development of novel therapeutics based on the bio

ATCC to Present New Data and Novel Cancer Model Offerings at AACR Annual Meeting

Sunday, March 31, 2019
PR Newswire

MANASSAS Va March PRNewswire At the

Gore Attending Two Upcoming Biopharmaceutical Conferences In April

Saturday, March 30, 2019
PR Newswire

NEWARK Del March PRNewswire WL Gore Associates Inc Gore a global materials science company announces its intention to participate in two upcoming life sciences conferences At the

Kymera Therapeutics to Present New Preclinical Data for its First-In-Class Oral IRAK4 Degrader in MYD88-Mutant Lymphoma at Late-Breaking Session of the American Association for Cancer Research Annual Meeting

Saturday, March 30, 2019
PR Newswire

CAMBRIDGE Mass March PRNewswire Kymera Therapeutics Inc a biotechnology company pioneering targeted protein degradation to create breakthrough medicines for patients will present new preclinical data for its firstinclass oral IRAK protein degrader...

Mareana Included in Gartner Research: Cited Among \"Clinical Vendors Building Value with AI Technology\"

Saturday, March 30, 2019
PR Newswire

PRINCETON NJ March PRNewswire Mareana today announced that it has been included in Gartners January artificial intelligence AI research note Life Sciences CIOs Accelerate Clinical Development with New Applications of Artificial Intelligence writ...

Black Diamond Therapeutics Presents Data From its Program Targeting Oncogenic Allosteric Mutations in EGFR for Glioblastoma as Late Breaker at the American Association for Cancer Research (AACR) Annual Meeting

Saturday, March 30, 2019
PR Newswire

CAMBRIDGE Mass March PRNewswire Black Diamond Therapeutics Inc a biotechnology company developing nextgeneration precision medicines for cancer today announced that data from its firstinclass program targeting a group of epidermal growth factor re...

Data Safety Monitoring Board Recommends Continuation Of Phase III Clinical Studies Of BACE Inhibitor Elenbecestat In Early Alzheimer\'s Disease

Saturday, March 30, 2019
PR Newswire

TOKYO March PRNewswire Eisai Co Ltd Headquarters Tokyo CEO Haruo Naito Eisai announced today that in the th meeting of the Data Safety Monitoring Board DSMB for the global Phase III clinical studies MISSION AD on the investigational oral B